Endocrinology

Fexofenadine shows promise as adjuvant therapy for diabetic kidney disease

Fexofenadine, when used in combination with ramipril, may be a promising adjuvant therapy for patients with diabetic kidney disease (DKD), according to a study. In this study, 61 patients were randomly assigned to 2 groups: the fexofenadine group (n = 30) receiving a combination of ramipril and fexofenadine, and the...